1. Home
  2. ATYR vs AOMR Comparison

ATYR vs AOMR Comparison

Compare ATYR & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.74

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

AOMR

Angel Oak Mortgage REIT Inc.

HOLD

Current Price

$8.77

Market Cap

224.3M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
AOMR
Founded
2005
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
224.3M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
ATYR
AOMR
Price
$0.74
$8.77
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$8.75
$11.13
AVG Volume (30 Days)
2.2M
96.7K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
14.70%
EPS Growth
N/A
N/A
EPS
N/A
0.73
Revenue
$190,000.00
$34,705,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18,728.88
$16.56
P/E Ratio
N/A
$11.88
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$7.36
52 Week High
$7.29
$10.88

Technical Indicators

Market Signals
Indicator
ATYR
AOMR
Relative Strength Index (RSI) 41.71 48.30
Support Level $0.70 $8.68
Resistance Level $0.83 $8.96
Average True Range (ATR) 0.05 0.13
MACD 0.01 0.02
Stochastic Oscillator 26.75 33.61

Price Performance

Historical Comparison
ATYR
AOMR

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About AOMR Angel Oak Mortgage REIT Inc.

Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation across interest rates and credit cycles.

Share on Social Networks: